Mettler-Toledo International Inc.
NYSE:MTDMedical - Diagnostics & Research
+$16.60 today
- Market cap
- $34.55B
- Beta
- 1.26
- P/E (TTM)
- 26.6
- EPS (TTM)
- $43.14
Volume 0.16M
Average 0.19M
MTD EBITDA Margin
EBITDA as a percentage of revenue.
Mettler-Toledo International Inc.NYSE: MTD
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin widens to 33.8%
EBITDA Margin was 33.8% in Q2 FY2026, up 3.7 pp from a year earlier. On a trailing-twelve-month basis it was 31.6%, up 0.0 pp year over year. Over 3 fiscal years it narrowed by 0.7 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 9 analysts of 32.9% for the fiscal year ending Dec 2026, up from 30.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 33.8%+6.4 pp QoQ
- Last fiscal yearDec 2025
- 30.9%-1.4 pp YoY
- LTMJun 2026
- 31.6%+0.0 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.7 pp | +0.8 pp | -2.9 pp |
| 1 year | -1.4 pp | +2.0 pp | +3.4 pp |
| 3 years | -0.7 pp | +4.9 pp | +5.6 pp |
| 5 years | +8.2 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 30.9%
- Year-over-year change
- -1.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 30.9% | -1.4pp |
| FY2024 | 2024-12-31 | 32.3% | +0.6pp |
| FY2023 | 2023-12-31 | 31.7% | +0.1pp |
| FY2022 | 2022-12-31 | 31.6% | +2.0pp |
| FY2021 | 2021-12-31 | 29.7% | — |
EBITDA Margin vs competitors
How MTD compares with its peers on the latest reported figures
- MTD's LTM Jun 2026 EBITDA Margin of 31.6% is the highest of the 10 companies compared; the peer median is 25.3%.
- Its year-over-year change of +0.0 pp is the 4th highest of 10, against a peer median of -1.8 pp.
- Over three fiscal years its change of -0.7 pp compares with a peer median of -2.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 31.6% | +0.0 pp | -0.7 pp | |
| LTM Sep 2026 | 27.7% | -0.6 pp | -7.3 pp | |
| LTM Jul 2026 | 27.6% | +1.1 pp | -1.4 pp | |
| LTM Jun 2026 | 26.7% | +1.1 pp | -2.5 pp | |
| LTM Jul 2026 | 26.3% | -3.0 pp | -8.9 pp | |
| LTM Sep 2026 | 25.3% | +2.0 pp | +0.0 pp | |
| LTM Sep 2026 | 23.7% | -2.2 pp | -0.9 pp | |
| LTM Jul 2026 | 20.5% | -14.2 pp | -2.3 pp | |
| LTM Oct 2026 | 14.6% | -1.8 pp | -3.0 pp | |
| LTM Jun 2026 | 7.1% | -4.6 pp | -11.7 pp | |
| Peer median (excluding MTD) | 25.3% | -1.8 pp | -2.5 pp | |
Competitors are the stored peer set for MTD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.72B | 3.92B | 3.79B | 3.87B | 4.03B |
| Cost of Revenue | 1.61B | 1.68B | 1.62B | 1.62B | 1.64B |
| Gross Profit | 2.11B | 2.24B | 2.17B | 2.25B | 2.39B |
| Gross Margin | 56.7% | 57.2% | 57.3% | 58.2% | 59.4% |
| Research & Development | 169.77M | 177.12M | 185.28M | 189.36M | 199.37M |
| Selling, General & Admin | 943.98M | 938.46M | 904.11M | 936.3M | 998.31M |
| Operating Expenses | 1.11B | 1.12B | 1.09B | 1.13B | 1.27B |
| Depreciation & Amortization | 108.06M | 113.02M | 121.16M | 123.22M | 125.61M |
| EBITDA | 1.1B | 1.24B | 1.2B | 1.25B | 1.24B |
| EBITDA Margin | 29.7% | 31.6% | 31.7% | 32.3% | 30.9% |
| Operating Income | 994.74M | 1.13B | 1.08B | 1.13B | 1.12B |
| Operating Margin | 26.8% | 28.7% | 28.5% | 29.1% | 27.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 43.24M | 55.39M | 77.37M | 74.63M | 68.52M |
| Other Income / Expenses | (45.38M) | (55.63M) | (105.96M) | (89.83M) | (69.58M) |
| Income Before Tax | 949.36M | 1.07B | 973.73M | 1.04B | 1.05B |
| Pre-Tax Margin | 25.5% | 27.3% | 25.7% | 26.8% | 26.1% |
| Income Tax Expense | 180.38M | 198.09M | 184.95M | 174.08M | 179.72M |
| Net Income | 768.99M | 872.5M | 788.78M | 863.14M | 869.19M |
| Net Margin | 20.7% | 22.3% | 20.8% | 22.3% | 21.6% |
| EPS (Basic) | 33.25 | 38.79 | 36.10 | 40.67 | 42.17 |
| EPS (Diluted) | 32.78 | 38.41 | 35.90 | 40.48 | 42.05 |
| Weighted Avg Shares | 23.13M | 22.49M | 21.85M | 21.22M | 20.61M |
| Weighted Avg Shares (Diluted) | 23.46M | 22.72M | 21.97M | 21.32M | 20.67M |
Mettler-Toledo International Inc.
NYSE:MTD
Intrinsic Alpha fair value
Locked
Current Price
$1,737.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.